0001209191-19-009916.txt : 20190213 0001209191-19-009916.hdr.sgml : 20190213 20190213201929 ACCESSION NUMBER: 0001209191-19-009916 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190211 FILED AS OF DATE: 20190213 DATE AS OF CHANGE: 20190213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bujarski Robert Joseph CENTRAL INDEX KEY: 0001333458 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 19600029 MAIL ADDRESS: STREET 1: C/O QUIDEL CORPORATION STREET 2: 12544 HIGH BLUFF DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-11 0 0000353569 QUIDEL CORP /DE/ QDEL 0001333458 Bujarski Robert Joseph 12544 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130 0 1 0 0 SVP, Bus Dev & Gen Counsel Common Stock 2019-02-11 4 A 0 2082 0.00 A 44950 D Common Stock 2019-02-11 4 F 0 676 60.75 D 44274 D Common Stock 2019-02-11 4 A 0 624 0.00 A 44898 D Common Stock 2019-02-11 4 F 0 213 60.75 D 44685 D Restricted Stock Units (Converted) 2019-02-11 4 A 0 2749 0.00 A Common Stock 2749 2749 D Restricted Stock Units (Premium) 2019-02-11 4 A 0 824 0.00 A Common Stock 824 824 D Reflects vesting of prior restricted stock units, which were previously reported on a Form 4. Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. The restricted stock units vest on the date of the grant, February 11, 2019. The restricted stock units were received in lieu of a percentage of the reporting person's 2018 cash bonus pursuant to the Quidel Corporation Deferred Bonus Compensation Plan. The restricted stock units vest on the first anniversary date of the grant date, February 11, 2020. Robert J. Bujarski 2019-02-13